Transcatheter options for atrial fibrillation treatment: an overview of the ablative techniques currently available and future perspectives.

ABSTRACT: Atrial fibrillation (AF) is the most common arrhythmia in the adult population and catheter ablation has emerged as an important rhythm-control strategy and is the most common cardiac ablation procedure performed worldwide. The antiarrhythmic drugs have demonstrated moderate efficacy in long-term maintenance of sinus rhythm; moreover, they are often not tolerated and are associated with adverse events. Catheter ablation has proven to be effective in treating AF, although long-term outcomes have been significantly less favorable in persistent AF than in paroxysmal. The current guidelines recommend catheter ablation as class I indication for patients whom antiarrhythmic drugs have failed or are not tolerated, and as first-line rhythm-control therapy in selected patients with symptomatic AF.

SUBMITTER: Penela D 

PROVIDER: S-EPMC10875204 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature